How biomedical papers accumulated their clinical citations: a large-scale retrospective analysis based on PubMed

Xin Li (), Xuli Tang () and Wei Lu ()
Additional contact information
Xin Li: Huazhong University of Science and Technology
Xuli Tang: Central China Normal University
Wei Lu: Wuhan University

Scientometrics, 2024, vol. 129, issue 6, No 17, 3315-3339

Abstract: Abstract This paper explored the temporal characteristics of clinical citations of biomedical papers, including how long it takes to receive its first clinical citation (the initial stage) and how long it takes to receive two or more clinical citations after its first clinical citation (the build-up stage). Over 23 million biomedical papers in PubMed between 1940 and 2013 and their clinical citations are used as the research data. We divide these biomedical papers into three groups and four categories from clinical citation level and translational science perspectives. We compare the temporal characteristics of biomedical papers of different groups or categories. From the perspective of clinical citation level, the results show that highly clinically cited papers had obvious advantages of receiving clinical citations over medium and lowly clinically cited papers in both the initial and build-up stages. Meanwhile, as the number of clinical citations increased in the build-up stage, the difference in the length of time to receive the corresponding number of clinical citations among the three groups of biomedical papers significantly increased. From the perspective of translational science, the results reveal that biomedical papers closer to clinical science more easily receive clinical citations than papers closer to basic science in both the initial and build-up stages. Moreover, we found that highly clinically cited papers had the desperate advantage of receiving clinical citations over even the clinical guidelines or clinical trials. The robustness analysis of the two aspects demonstrates the reliability of our results. The indicators proposed in this paper could be useful for pharmaceutical companies and government policy-makers to monitor the translational progress of biomedical research. Besides, the findings in this study could be interesting for young scholars in biomedicine to get more attention from clinical science and to obtain success in their scientific careers, especially for those in basic science.

Keywords: Clinical citation; Temporal characteristics; Clinical citation level; Translational science; Robustness analysis (search for similar items in EconPapers)
Date: 2024
References: View references in EconPapers View complete reference list from CitEc
Citations: View citations in EconPapers (1)

Downloads: (external link)
http://link.springer.com/10.1007/s11192-024-05016-0 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:spr:scient:v:129:y:2024:i:6:d:10.1007_s11192-024-05016-0

Ordering information: This journal article can be ordered from
http://www.springer.com/economics/journal/11192

DOI: 10.1007/s11192-024-05016-0

Access Statistics for this article

Scientometrics is currently edited by Wolfgang Glänzel

More articles in Scientometrics from Springer, Akadémiai Kiadó
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().